Drug Trial Radar · NCT07810972
Evaluate the Safety and Efficacy of TJO-087
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
90
Actual
Start
Apr 6, 2026
Primary completion
Oct 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Taejoon Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to evaluate the therapeutic efficacy and safety of investigational product compared with placebo in adult patients with dry eye disease. Patients will receive investigational product or placebo for 3 months, and the therapeutic effect will be assessed based on the change in corneal staining score from baseline.
Conditions
- Dry Eye Syndrome (DES)
Interventions
TJO-087Drug
one drop in each eye, twice daily (1 drop of IP, 1 drop of placebo)
TJO-087Drug
one drop in each eye, twice daily (2 dose of IP)
Vehicle (Placebo solution)Drug
one drop in each eye, twice daily (2 dose of placebo)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Corneal Staining Score at 12 weeksTime frame: Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Korea University Guro Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.